Home > Boards > US OTC > Biotechs > Sunshine Biopharma Inc. (SBFM)

It's warming up now for a MEGA BREAK-OUT!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Babubd Member Profile
Member Level 
Followed By 265
Posts 17,739
Boards Moderated 10
Alias Born 04/26/19
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2021 4:55:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2021 12:37:30 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 10/6/2021 6:01:19 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 9/21/2021 6:02:36 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2021 12:02:42 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/29/2021 4:47:38 PM
Sunshine Biopharma reports Q1 results Seeking Alpha - 5/13/2021 8:50:07 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/30/2021 3:24:52 PM
Sunshine gets new patent application notice of allowance for adva-27a in Europe until 2033 Seeking Alpha - 3/11/2021 9:19:08 AM
CLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History InvestorsHub NewsWire - 3/9/2021 6:37:33 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2021 12:37:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2021 12:34:31 PM
Sunshine Bio launches COVID-19 treatment mice study Seeking Alpha - 2/10/2021 8:48:46 AM
SUNSHINE BIOPHARMA INITIATES COVID-19 TREATMENT MICE STUDY InvestorsHub NewsWire - 2/10/2021 8:00:00 AM
CLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating Target InvestorsHub NewsWire - 2/9/2021 6:48:48 AM
SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF GEORGIA FOR COVID-19 COMPOUNDS InvestorsHub NewsWire - 2/4/2021 8:00:00 AM
SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT APPLICATION EXTENDING InvestorsHub NewsWire - 2/2/2021 8:00:00 AM
CLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New Products InvestorsHub NewsWire - 2/2/2021 6:52:54 AM
SUNSHINE BIOPHARMA COMPLETES APPLICATION TO UPLIST TO OTCQB InvestorsHub NewsWire - 1/27/2021 8:20:00 AM
Epazz, Inc. (OTC Pink: EPAZ) Capitalizes on Blockchain through StreamPay App InvestorsHub NewsWire - 1/26/2021 7:00:00 AM
SUNSHINE BIOPHARMA'S CORONAVIRUS TREATMENT ANTICIPATED TO BE EFFECTIVE AGAINST THE NEW VARIANT IDENTIFIED IN THE UK InvestorsHub NewsWire - 12/22/2020 8:00:00 AM
SUNSHINE BIOPHARMA ORDERS A NEW BATCH OF Adva-27a FOR TESTING ON TOPII AMPLIFIED CANCERS InvestorsHub NewsWire - 12/8/2020 8:00:00 AM
SUNSHINE BIOPHARMA PAYS OFF CONVERTIBLE NOTES IN CASH PREVENTING NEW SHARES FROM HITTING THE MARKET InvestorsHub NewsWire - 12/3/2020 8:00:00 AM
SUNSHINE BIOPHARMA RECEIVES THIRD TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT InvestorsHub NewsWire - 12/1/2020 8:00:00 AM
Babubd Member Level  Wednesday, 10/06/21 10:09:22 AM
Re: None
Post # of 102388 
It's warming up now for a MEGA BREAK-OUT! Folks, COVID-19 Drug/Capsules/Pills Plus Cancer Drugs incoming!! FDA Approval Submission and then a Partnership or Buy-Out offer from a Pharma giant like, Pfizer Inc. or Johnson and Johnson Inc. will send the PPS to Dollars!!

We Know, Biotech stock GLSI ran from $3 through $158 in a single day couple of months ago! I think SBFM is NEXT!!


Know What You Own:

Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases

MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has filed a patent application for a potential new treatment for neurodegenerative disorders. Sunshine Biopharma’s patent application contains experimental results showing that certain mRNA molecules provide protective effects against oxidative stress in differentiated neuronal cells, a process that mimics neuronal degeneration. This new patent application has a priority date of October 1, 2021.

Neurodegeneration refers to the progressive loss of neuronal function, which may ultimately result in cell death. Neurodegenerative diseases include amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis, Alzheimer's disease, and Huntington's disease. Neurodegeneration can occur in the brain as well as in the peripheral nervous system. At present, there is no known way to reverse the progressive degeneration of neurons and as such these diseases are considered to be incurable.

Recent biochemical studies have revealed many underlying similarities among these diseases at the sub-cellular level. These similarities suggest that a given therapeutic approach for one neurodegenerative disease might ameliorate other diseases in the class.

Neurodegenerative diseases affect millions of people worldwide. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases. According to the CDC, as many as 5.8 million Americans were living with Alzheimer's disease in 2020. An estimated 1.2 million people in the United States could be living with Parkinson’s disease by 2030. There is currently no way to slow down the progression of these and other neurodegenerative diseases.

“We are heartened by this recent finding in our ongoing mRNA-as-therapeutic-agents research that certain mRNA molecules provide differentiated neuronal cells full protection against hydrogen peroxide induced oxidative stress, a system commonly used to study neurodegeneration in vitro,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are excited about this discovery for patients suffering from neurodegenerative disorders. Our possible mRNA treatment could arrest progression of neurodegeneration, alleviate symptoms, relieve pain, and increase mobility,” he added.
https://ca.finance.yahoo.com/news/sunshine-biopharma-files-patent-application-120000636.html

Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern, 2021-08-12 !! Just amazing !!
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000512.html

Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer, 2021-07-08!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-employs-mrna-vaccine-130000648.html

Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types, 2021-05-25 - This is gonna be HUGE beyond imagination!
https://ca.finance.yahoo.com/news/sunshine-biopharma-adva-27a-destroys-120000080.html

Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application, 2021-05-04.
https://ca.finance.yahoo.com/news/sunshine-biopharma-upgrades-covid-19-120000354.html

Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment, 2021-04-19..Just amazing!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-favorable-mtd-120000152.html

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a, the Company's Flagship Anticancer Compound Until 2033-Just Beautiful!
https://finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-130000340.html

SBFM has a number of shares outstanding only 510.09 million including restricted shares of 60.01 Million. Biotech stock with huge potential and such a low OS in OTC, PPS @ $2..$5..$7..$10..$20..$25++??, anything is possible.
https://www.otcmarkets.com/stock/SBFM/security

Shorts are Screwed up here. Total Naked Shorted Position is 15.313 Million. Huge Short Squeeze is imminent. Shorts are gonna be scrambling, weeping and biting their nails.
https://marketwirenews.com/stock/sbfm/short/

Let's go SBFM to $5++ and NASDAQ !!

SHARE VALUATION:

As per MNP (one of the largest public accountancy firms in Canada), an estimated Fair Market Value of issued and outstanding shares of SBFM as at March 31, 2017 was in the range of $977.0 million to $1,133.0 million.

https://finance.yahoo.com/news/sunshine-biopharma-releases-results-independent-130000009.html

So, Estimated PPS of SBFM (in 2017) = $1,100 million/510.09 million = $2.16 (without recent developments)

Folks! act prudently and be financially solvent at this very very difficult time.

RECENT DEVELOPMENTS:

Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-0-9-130000806.html

Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned, 2021-06-09
https://ca.finance.yahoo.com/news/sunshine-biopharma-mice-study-covid-130000849.html

Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting
https://ca.finance.yahoo.com/news/sunshine-biopharma-eliminates-250-000-120000108.html

Sunshine Biopharma Reports $1.797 Million Cash in 2021 Q1 Filing
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-improved-cash-120000104.html

RB Capital Increases Investment in Sunshine Biopharma
https://ca.finance.yahoo.com/news/rb-capital-increases-investment-sunshine-120000335.html

Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-reaches-2-000-130000199.html

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033, 2021-03-11
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-140000158.html

Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-recently-ordered-140000929.html

Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
https://ca.finance.yahoo.com/news/sunshine-biopharma-launches-ecommerce-store-141400955.html

Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds, Feb. 4, 2021
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-exclusive-license-130000848.html

Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-fourth-tranche-133000911.html

Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK, Dec. 22, 2020

https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000305.html

Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers, Dec. 8, 2020

https://ca.finance.yahoo.com/news/sunshine-biopharma-orders-batch-adva-130000761.html

Sunshine Biopharma Paid Off Convertible Notes in Cash Preventing New Shares From Hitting the Market, December 3, 2020..Just Beautiful!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-pays-off-convertible-130000473.html

Sunshine Biopharma Signed an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound....This is a HUGE NEWS!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-agreement-montreal-130000919.html

https://wallstreetwindow.com/2020/10/shares-of-sunshine-biopharma-inc-otcmkts-sbfm-rise-today-on-covid-drug-news-tim-bellamy-10-19-2020/


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences